Press Releases
Press Releases
CiToxLAB Group announces a 34 per cent revenue increase for the first half of 2012
CiToxLAB Group, a leading CRO in the field of non-clinical research, announces today that the group’s consolidated first half 2012 revenues reached EUR 37.2M (USD 48.4 million approximately). This marks a 34 per cent increase compared with the...
Press Releases
AIBioTech Expands Bioorganic Chemistry Platform
AIBioTech is quickly gaining ground in the niche market of custom synthesis of small molecules, including molecules which contain stable isotopes of particular atoms. The products of these syntheses are routinely used by our customers...
Press Releases
Endo Tools Therapeutics completes first-in-human cases with its Endomina triangulation platform
Endo Tools Therapeutics, a developer of advanced, minimally-invasive medical devices to treat obesity, digestive tract tumors and type II diabetes, announces today the completion of several first-in-human cases where Endo Tools' new Endomina(TM) triangulation platform has been used....
Press Releases
Biophytis will use funds to continue development of its nutraceuticals pipeline and to develop drug candidates derived from nutraceutical active substances for the treatment...
Biophytis, a research company in health and nutrition focusing on metabolic disorders and age-related diseases, announces today that it has raised EUR two million (USD 2.6M) in a B round. Metabrain Research, a spin-off of Merck Serono based...
Press Releases
Impax Laboratories Announces Settlement of Litigation Relating to CONCERTA®
Impax Laboratories, Inc.today announced that it and Teva Pharmaceuticals USA, Inc. have reached agreement with Janssen Pharmaceuticals, Inc. and ALZA Corporation (together, “ALZA”) to settle pending U.S. litigation with regard to the production and sale of generic formulations...
Press Releases
Oncodesign enters into a research collaboration and license agreement with Sanofi for the application of Oncodesign¹s Nanocyclix(R) technology to Sanofi¹s kinase targets
Oncodesign, a drug discovery company and oncology pharmacology service provider, announces today that the company has entered into a strategic research collaboration with Sanofi to apply exclusively Oncodesign’s Nanocyclix(R) technology to several Sanofi kinase target programs. ...
Press Releases
Torax Medical Names Veteran Industry Executive to Lead Global Commercialization Effort
Torax Medical announced today that Eric Masingale has joined the company as Global Vice President of Sales and Marketing. Eric comes to Torax Medical after 18 years with Stryker Corp (NYSE: SYK), where he...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read